United States Pomalidomide Market Report 2016

September 2016 | 116 pages | ID: U3A6F633D69EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Pomalidomide

Revenue, means the sales value of Pomalidomide

This report studies sales (consumption) of Pomalidomide in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer
• Allergan
• Alnylam Pharmaceuticals
• Amgen
• Angstrom Pharmaceuticals
• Acceleron Pharma
• Biocon
• Bionomics
• CASI Pharmaceuticals
• Celgene Corporation
• Enzon Pharmaceuticals
• Five Prime Therapeutics
• Fujifilm Kyowa Kirin Biologics
• Genentech
• Genexine
• Hetero Drugs
• ImClone Systems
• Intas Pharmaceuticals
• Kyowa Hakko Kirin
• Levolta Pharmaceuticals
• Mabtech
• Marsala Biotech
• Neumedicines
• Novartis
• Oncobiologics
• Onyx Pharmaceuticals

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Pomalidomide in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Pomalidomide Market Report 2016

1 POMALIDOMIDE OVERVIEW

1.1 Product Overview and Scope of Pomalidomide
1.2 Classification of Pomalidomide
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Pomalidomide
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Pomalidomide (2011-2021)
  1.4.1 USA Pomalidomide Sales and Growth Rate (2011-2021)
  1.4.2 USA Pomalidomide Revenue and Growth Rate (2011-2021)

2 USA POMALIDOMIDE COMPETITION BY MANUFACTURERS

2.1 USA Pomalidomide Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Pomalidomide Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Pomalidomide Average Price by Manufactures (2015 and 2016)
2.4 Pomalidomide Market Competitive Situation and Trends
  2.4.1 Pomalidomide Market Concentration Rate
  2.4.2 Pomalidomide Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 USA POMALIDOMIDE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 USA Pomalidomide Sales and Market Share by Type (2011-2016)
3.2 USA Pomalidomide Revenue and Market Share by Type (2011-2016)
3.3 USA Pomalidomide Price by Type (2011-2016)
3.4 USA Pomalidomide Sales Growth Rate by Type (2011-2016)

4 USA POMALIDOMIDE SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 USA Pomalidomide Sales and Market Share by Application (2011-2016)
4.2 USA Pomalidomide Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 USA POMALIDOMIDE MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Pomalidomide Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Allergan
  5.2.2 Pomalidomide Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Allergan Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Alnylam Pharmaceuticals
  5.3.2 Pomalidomide Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Alnylam Pharmaceuticals Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Amgen
  5.4.2 Pomalidomide Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Amgen Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Angstrom Pharmaceuticals
  5.5.2 Pomalidomide Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Angstrom Pharmaceuticals Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Acceleron Pharma
  5.6.2 Pomalidomide Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Acceleron Pharma Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Biocon
  5.7.2 Pomalidomide Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Biocon Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Bionomics
  5.8.2 Pomalidomide Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Bionomics Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 CASI Pharmaceuticals
  5.9.2 Pomalidomide Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 CASI Pharmaceuticals Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Celgene Corporation
  5.10.2 Pomalidomide Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Celgene Corporation Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Enzon Pharmaceuticals
5.12 Five Prime Therapeutics
5.13 Fujifilm Kyowa Kirin Biologics
5.14 Genentech
5.15 Genexine
5.16 Hetero Drugs
5.17 ImClone Systems
5.18 Intas Pharmaceuticals
5.19 Kyowa Hakko Kirin
5.20 Levolta Pharmaceuticals
5.21 Mabtech
5.22 Marsala Biotech
5.23 Neumedicines
5.24 Novartis
5.25 Oncobiologics
5.26 Onyx Pharmaceuticals

6 POMALIDOMIDE MANUFACTURING COST ANALYSIS

6.1 Pomalidomide Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Pomalidomide

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Pomalidomide Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Pomalidomide Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 USA POMALIDOMIDE MARKET FORECAST (2016-2021)

10.1 USA Pomalidomide Sales, Revenue Forecast (2016-2021)
10.2 USA Pomalidomide Sales Forecast by Type (2016-2021)
10.3 USA Pomalidomide Sales Forecast by Application (2016-2021)
10.4 Pomalidomide Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Pomalidomide
Table Classification of Pomalidomide
Figure USA Sales Market Share of Pomalidomide by Type in 2015
Table Application of Pomalidomide
Figure USA Sales Market Share of Pomalidomide by Application in 2015
Figure USA Pomalidomide Sales and Growth Rate (2011-2021)
Figure USA Pomalidomide Revenue and Growth Rate (2011-2021)
Table USA Pomalidomide Sales of Key Manufacturers (2015 and 2016)
Table USA Pomalidomide Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Pomalidomide Sales Share by Manufacturers
Figure 2016 Pomalidomide Sales Share by Manufacturers
Table USA Pomalidomide Revenue by Manufacturers (2015 and 2016)
Table USA Pomalidomide Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Pomalidomide Revenue Share by Manufacturers
Table 2016 USA Pomalidomide Revenue Share by Manufacturers
Table USA Market Pomalidomide Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Pomalidomide Average Price of Key Manufacturers in 2015
Figure Pomalidomide Market Share of Top 3 Manufacturers
Figure Pomalidomide Market Share of Top 5 Manufacturers
Table USA Pomalidomide Sales by Type (2011-2016)
Table USA Pomalidomide Sales Share by Type (2011-2016)
Figure USA Pomalidomide Sales Market Share by Type in 2015
Table USA Pomalidomide Revenue and Market Share by Type (2011-2016)
Table USA Pomalidomide Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Pomalidomide by Type (2011-2016)
Table USA Pomalidomide Price by Type (2011-2016)
Figure USA Pomalidomide Sales Growth Rate by Type (2011-2016)
Table USA Pomalidomide Sales by Application (2011-2016)
Table USA Pomalidomide Sales Market Share by Application (2011-2016)
Figure USA Pomalidomide Sales Market Share by Application in 2015
Table USA Pomalidomide Sales Growth Rate by Application (2011-2016)
Figure USA Pomalidomide Sales Growth Rate by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Pomalidomide Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Pomalidomide Sales Market Share (2011-2016)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alnylam Pharmaceuticals Pomalidomide Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Pomalidomide Sales Market Share (2011-2016)
Table Angstrom Pharmaceuticals Basic Information List
Table Angstrom Pharmaceuticals Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Angstrom Pharmaceuticals Pomalidomide Sales Market Share (2011-2016)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Acceleron Pharma Pomalidomide Sales Market Share (2011-2016)
Table Biocon Basic Information List
Table Biocon Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biocon Pomalidomide Sales Market Share (2011-2016)
Table Bionomics Basic Information List
Table Bionomics Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bionomics Pomalidomide Sales Market Share (2011-2016)
Table CASI Pharmaceuticals Basic Information List
Table CASI Pharmaceuticals Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table CASI Pharmaceuticals Pomalidomide Sales Market Share (2011-2016)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celgene Corporation Pomalidomide Sales Market Share (2011-2016)
Table Enzon Pharmaceuticals Basic Information List
Table Enzon Pharmaceuticals Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Enzon Pharmaceuticals Pomalidomide Sales Market Share (2011-2016)
Table Five Prime Therapeutics Basic Information List
Table Five Prime Therapeutics Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Five Prime Therapeutics Pomalidomide Sales Market Share (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Basic Information List
Table Fujifilm Kyowa Kirin Biologics Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Pomalidomide Sales Market Share (2011-2016)
Table Genentech Basic Information List
Table Genentech Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Pomalidomide Sales Market Share (2011-2016)
Table Genexine Basic Information List
Table Genexine Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genexine Pomalidomide Sales Market Share (2011-2016)
Table Hetero Drugs Basic Information List
Table Hetero Drugs Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hetero Drugs Pomalidomide Sales Market Share (2011-2016)
Table ImClone Systems Basic Information List
Table ImClone Systems Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table ImClone Systems Pomalidomide Sales Market Share (2011-2016)
Table Intas Pharmaceuticals Basic Information List
Table Intas Pharmaceuticals Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Intas Pharmaceuticals Pomalidomide Sales Market Share (2011-2016)
Table Kyowa Hakko Kirin Basic Information List
Table Kyowa Hakko Kirin Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kyowa Hakko Kirin Pomalidomide Sales Market Share (2011-2016)
Table Levolta Pharmaceuticals Basic Information List
Table Levolta Pharmaceuticals Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Levolta Pharmaceuticals Pomalidomide Sales Market Share (2011-2016)
Table Mabtech Basic Information List
Table Mabtech Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mabtech Pomalidomide Sales Market Share (2011-2016)
Table Marsala Biotech Basic Information List
Table Marsala Biotech Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Marsala Biotech Pomalidomide Sales Market Share (2011-2016)
Table Neumedicines Basic Information List
Table Neumedicines Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neumedicines Pomalidomide Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Pomalidomide Sales Market Share (2011-2016)
Table Oncobiologics Basic Information List
Table Oncobiologics Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Oncobiologics Pomalidomide Sales Market Share (2011-2016)
Table Onyx Pharmaceuticals Basic Information List
Table Onyx Pharmaceuticals Pomalidomide Sales, Revenue, Price and Gross Margin (2011-2016)
Table Onyx Pharmaceuticals Pomalidomide Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pomalidomide
Figure Manufacturing Process Analysis of Pomalidomide
Figure Pomalidomide Industrial Chain Analysis
Table Raw Materials Sources of Pomalidomide Major Manufacturers in 2015
Table Major Buyers of Pomalidomide
Table Distributors/Traders List
Figure USA Pomalidomide Production and Growth Rate Forecast (2016-2021)
Figure USA Pomalidomide Revenue and Growth Rate Forecast (2016-2021)
Table USA Pomalidomide Production Forecast by Type (2016-2021)
Table USA Pomalidomide Consumption Forecast by Application (2016-2021)